Treatment of prolactinomas with megavoltage radiotherapy.

Treatment of prolactinomas with megavoltage radiotherapy.

Pokaż inne wersje (1)

The outcome of treatment of 36 women with prolactinomas using megavoltage radiotherapy combined with interim dopamine agonists (bromocriptine, lysuride, pergolide) was reviewed; 16 of the women showed radiological evidence of a macroadenoma. The most common presenting symptom was secondary amenorrho...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Grossman, A, Cohen, B, Charlesworth, M, Plowman, P, Rees, L, Wass, J, Jones, A, Besser, G
Format:	Journal article
Język:	English
Wydane:	1984

Podobne zapisy

Treatment of prolactinomas with megavoltage radiotherapy.
od: Grossman, A, i wsp.
Wydane: (1984)

Megavoltage pituitary irradiation in the management of prolactinomas: long-term follow-up.
od: Tsagarakis, S, i wsp.
Wydane: (1991)

Prolactinomas presenting as primary amenorrhoea and delayed or arrested puberty: response to medical therapy.
od: Howlett, T, i wsp.
Wydane: (1989)

Depot-bromocriptine treatment for prolactinomas and acromegaly.
od: Grossman, A, i wsp.
Wydane: (1986)

DEPOT BROMOCRIPTINE IN THE TREATMENT OF PROLACTINOMAS AND ACROMEGALY
od: Grossman, A, i wsp.
Wydane: (1985)

Prolactinomas.
od: Grossman, A, i wsp.
Wydane: (1985)

PROLACTINOMA IN A PREPUBERTAL CHILD - RESPONSE TO SURGERY, RADIOTHERAPY AND DOPAMINE AGONIST THERAPY
od: Sinn, D, i wsp.
Wydane: (1985)

PROLACTINOMAS - REPLY
od: Grossman, A, i wsp.
Wydane: (1985)

When to discontinue treatment of prolactinoma?
od: Wass, J
Wydane: (2006)

Massive prolactinoma with galactorrhoea in a prepubertal boy.
od: Ross, R, i wsp.
Wydane: (1989)

Radiotherapy in the treatment of pituitary tumors.
od: Plowman, P, i wsp.
Wydane: (1990)

Valvular heart disease and the use of cabergoline for the treatment of prolactinoma.
od: Herring, N, i wsp.
Wydane: (2009)

Malignant prolactinoma with extracranial metastases: a report of three cases.
od: Walker, J, i wsp.
Wydane: (1993)

The long-term outcome after adrenalectomy and prophylactic pituitary radiotherapy in adrenocorticotropin-dependent Cushing's syndrome.
od: Jenkins, P, i wsp.
Wydane: (1995)

Second brain tumour after treatment for pituitary adenoma.
od: Wass, J, i wsp.
Wydane: (1992)

Characterisation of a MOSFET-based detector for dose measurement under megavoltage electron beam radiotherapy
od: Jong, Wei Loong, i wsp.
Wydane: (2018)

Diagnosis and management of prolactinomas and non-functioning pituitary adenomas.
od: Rogers, A, i wsp.
Wydane: (2014)

Growth hormone releasing factor: comparison of two analogues and demonstration of hypothalamic defect in growth hormone release after radiotherapy.
od: Grossman, A, i wsp.
Wydane: (1984)

Intermediate Megavoltage Photon Beams for Improved Lung Cancer Treatments.
od: Ying Zhang, i wsp.
Wydane: (2015-01-01)

Characterization of the on-board megavoltage imager in a magnetic resonance-guided radiotherapy machine for beam output checks
od: Guido C. Hilgers, i wsp.
Wydane: (2024-01-01)

Acceleration of pubertal development following pituitary radiotherapy for Cushing's disease.
od: Nicholl, R, i wsp.
Wydane: (1993)

Use of megavoltage cine-images for studying intra-thoracic motion during radiotherapy for locally advanced lung cancer.
od: Muirhead, R, i wsp.
Wydane: (2011)

Gamma knife radiosurgery: a safe and effective salvage treatment for pituitary tumours not controlled despite conventional radiotherapy.
od: Swords, F, i wsp.
Wydane: (2009)

Association of prolactin receptor (PRLR) variants with prolactinomas
od: Gorvin, C, i wsp.
Wydane: (2018)

Treatment of Prolactinomas in Low-Income Countries
od: Ivan Kruljac, i wsp.
Wydane: (2015-01-01)

Clinical and endocrine responses to pituitary radiotherapy in pediatric Cushing's disease: an effective second-line treatment.
od: Storr, H, i wsp.
Wydane: (2003)

Long-term anterior pituitary function in patients with paediatric Cushing's disease treated with pituitary radiotherapy.
od: Chan, L, i wsp.
Wydane: (2007)

Comparison of the clinical activity of mesulergine and pergolide in the treatment of hyperprolactinaemia.
od: Grossman, A, i wsp.
Wydane: (1985)

What are the markers of aggressiveness in prolactinomas? Changes in cell biology, extracellular matrix components, angiogenesis and genetics.
od: Gürlek, A, i wsp.
Wydane: (2007)

Anterior pituitary function in the long-term follow-up of five paediatric Cushing's disease patients treated with pituitary radiotherapy
od: Chan, L, i wsp.
Wydane: (2006)

Use of fabricated germanium-doped optical fibres for radiotherapy postal dose audit of megavoltage photon beams under non-reference conditions in selected Malaysian radiotherapy facilities
od: Ahmad Fadzil, Muhammad Safwan
Wydane: (2020)

Empirical modeling of the percent depth dose for megavoltage photon beams.
od: Xiao-Jun Li, i wsp.
Wydane: (2022-01-01)

ENHANCING HYPOTHALAMIC-LESIONS SHOWN ON HIGH-RESOLUTION COMPUTERIZED-TOMOGRAPHY IN PATIENTS WITH IDIOPATHIC HYPOPITUITARISM
od: Charlesworth, M, i wsp.
Wydane: (1986)

ENHANCING HYPOTHALAMIC-LESIONS SHOWN ON HIGH-RESOLUTION COMPUTERIZED-TOMOGRAPHY IN PATIENTS WITH IDIOPATHIC HYPOPITUITARISM
od: Charlesworth, M, i wsp.
Wydane: (1986)

Evidence for the effectiveness of radiotherapy in the treatment of acromegaly.
od: Wass, J
Wydane: (1997)

Dosimetry audit for megavoltage photon beams applied in non-reference conditions
od: Ahmad Fadzil, Muhammad Safwan, i wsp.
Wydane: (2022)

Familial prolactinoma and paraganglioma: A new clinical entity?
od: Walker, L, i wsp.
Wydane: (2005)

Pathogenesis, diagnosis and current treatment of prolactinoma: a review of the literature
od: Monika Szyszka, i wsp.
Wydane: (2024-07-01)

The course of pregnancy and delivery in patients with prolactinoma during treatment with cabergoline
od: Larisa Dzeranova, i wsp.
Wydane: (2016-11-01)

Recurrence of hyperprolactinaemia following discontinuation of dopamine agonist therapy in patients with prolactinoma occurs commonly especially in macroprolactinoma.
od: Barber, T, i wsp.
Wydane: (2011)